<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:slash="http://purl.org/rss/1.0/modules/slash/">
  <channel>
    <title>Healthcare industry BW</title>
    <description>Healthcare industry BW</description>
    <generator>Laminas_Feed_Writer 2 (https://getlaminas.org)</generator>
    <link>https://www.gesundheitsindustrie-bw.de/en</link>
    <item>
      <title>ViferaXS Raises €12 Million to Advance Phase II Trial in Chronic Lymphocytic Leukemia and Expand Its Oncology Pipeline</title>
      <description><![CDATA[ViferaXS, a clinical-stage biotechnology company developing peptide-based cancer immunotherapy for hematologic malignancies and solid tumors, today announced the close of the Series A financing round of up to €12 million, including grant funding. The round was led by SPRIND, the German Federal Agency for Breakthrough Innovation, and Huma, with participation from private investors.]]></description>
      <pubDate>Wed, 23 Sep 2026 14:11:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/article/press-release/viferaxs-raises-euro-12-million-advance-phase-ii-trial-chronic-lymphocytic-leukemia-and-expand-its-oncology-pipeline</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/article/press-release/viferaxs-raises-euro-12-million-advance-phase-ii-trial-chronic-lymphocytic-leukemia-and-expand-its-oncology-pipeline</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>The digital twin – shaping the future of neonatal medicine</title>
      <description><![CDATA[Virtually every newborn undergoes routine screening shortly after birth to detect congenital disorders. These examinations have generated a unique wealth of data on early childhood development. However, for many years this valuable resource remained largely untapped. That all changed when researchers in Heidelberg started to use the data to develop a digital twin for newborns. Today, the technology is on the verge of entering clinical practice.]]></description>
      <pubDate>Tue, 22 Sep 2026 07:00:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/article/news/digital-twin-shaping-future-neonatal-medicine</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/article/news/digital-twin-shaping-future-neonatal-medicine</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>New technique could make MRI more precise</title>
      <description><![CDATA[A team of researchers at the University of Stuttgart has developed a new method that could make MRI even more precise by eliminating “dead time,” a key limiting factor in the measurement process, thereby enabling the detection of signals that are lost using conventional methods. This method opens up new possibilities for medical diagnostics and non-destructive materials testing. The research team presents the new approach in Science Advances.]]></description>
      <pubDate>Thu, 17 Sep 2026 07:35:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-technique-could-make-mri-more-precise</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-technique-could-make-mri-more-precise</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Introduction to Planetary Protection</title>
      <description><![CDATA[Kein Inhalt]]></description>
      <pubDate>Thu, 17 Sep 2026 06:58:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/event/introduction-planetary-protection-en</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/event/introduction-planetary-protection-en</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Professor Jakob Nikolas Kather Appointed Hopp Foundation Professor of “Artificial Intelligence in Medicine” and Founding Director of the New Institute for Medical AI (IMAI) in Heidelberg</title>
      <description><![CDATA[Effective 1 October 2026, Professor Jakob Nikolas Kather will assume the Hopp Foundation Professorship for “Artificial Intelligence in Medicine” at the Heidelberg Faculty of Medicine at Heidelberg University. Associated with the professorship is the establishment of the new Institute for Medical AI (IMAI) at Heidelberg University Hospital, which Professor Kather will lead as its founding director.]]></description>
      <pubDate>Wed, 16 Sep 2026 15:15:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/article/press-release/professor-jakob-nikolas-kather-appointed-hopp-foundation-professor-artificial-intelligence-medicine-and-founding-director-new-in</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/article/press-release/professor-jakob-nikolas-kather-appointed-hopp-foundation-professor-artificial-intelligence-medicine-and-founding-director-new-in</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>New collaboration on DNA nanotechnology</title>
      <description><![CDATA[Prof. Chunhai Fan, who is a recipient of the Humboldt Research Award, has been conducting research at the University of Stuttgart since June. Fan works closely with Prof. Laura Na Liu of the 2nd Physics Institute. Both researchers are among the world's leading experts in the field of DNA nanotechnology.]]></description>
      <pubDate>Thu, 10 Sep 2026 08:07:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-collaboration-dna-nanotechnology</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-collaboration-dna-nanotechnology</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>International Research on Bioengineering of the Mitochondrial Genome</title>
      <description><![CDATA[While the cell nucleus contains almost all of the genome, the mitochondria – the powerhouses of the cell – have their own small genetic code. It consists of only 37 genes, which are organized in circular DNA – mtDNA, for short. Defects in the mitochondrial genome are related to incurable neurodegenerative and metabolic diseases, cancer and also aging processes.]]></description>
      <pubDate>Wed, 09 Sep 2026 10:12:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/article/press-release/international-research-bioengineering-mitochondrial-genome</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/article/press-release/international-research-bioengineering-mitochondrial-genome</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Quality Over Quantity: New Insights into the Role of Specific CAR T Cells in Cancer Therapy</title>
      <description><![CDATA[CAR T-cell therapies are used successfully to treat certain blood cancers. However, while some patients respond even to low-dose treatment, others derive no benefit. Researchers from the Heidelberg Faculty of Medicine at Heidelberg University and the Berlin Institute of Health at Charité (BIH) investigated the reasons behind these differences in a collaborative research project.]]></description>
      <pubDate>Tue, 08 Sep 2026 09:42:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/article/press-release/quality-over-quantity-new-insights-role-specific-car-t-cells-cancer-therapy</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/article/press-release/quality-over-quantity-new-insights-role-specific-car-t-cells-cancer-therapy</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Heisenberg Professorship for Aurélie Ernst</title>
      <description><![CDATA[With funding from the German Research Foundation’s (DFG) Heisenberg Program, DKFZ researcher Aurélie Ernst aims to investigate how massive changes in the genome contribute to the development of cancer. Her research focuses on a phenomenon known as chromothripsis - a catastrophic event in the genome in which chromosomes break apart and are reassembled incorrectly.]]></description>
      <pubDate>Tue, 08 Sep 2026 09:27:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/article/press-release/heisenberg-professorship-aurelie-ernst</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/article/press-release/heisenberg-professorship-aurelie-ernst</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>AI and robotics are shaping the future of medicine</title>
      <description><![CDATA[Artificial intelligence and robotics are playing an increasingly important role in healthcare, as in many other areas of life. They offer considerable potential to improve medical care, but require an ethically responsible approach.]]></description>
      <pubDate>Tue, 08 Sep 2026 07:00:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/article/dossier/ai-and-robotics-are-shaping-future-medicine</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/article/dossier/ai-and-robotics-are-shaping-future-medicine</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>REHAB 2027</title>
      <description><![CDATA[Kein Inhalt]]></description>
      <pubDate>Mon, 07 Sep 2026 07:53:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/event/rehab-2027-en</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/event/rehab-2027-en</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Triple ERC Success at the German Cancer Research Center</title>
      <description><![CDATA[Three researchers at the German Cancer Research Center (DKFZ) have each been awarded a Starting Grant from the European Research Council (ERC) this year. Daniel Kirschenbaum, Lena Kutscher, and Michael Scherer impressed the ERC with their innovative research approaches to fundamental questions in cancer medicine.]]></description>
      <pubDate>Thu, 03 Sep 2026 13:18:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/article/press-release/triple-erc-success-german-cancer-research-center</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/article/press-release/triple-erc-success-german-cancer-research-center</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>ERC Starting Grant for Heidelberg Neurologist and Neuroscientist Dr. Dr. Varun Venkataramani</title>
      <description><![CDATA[Cells of the highly aggressive brain tumor glioblastoma exhibit predatory behavior: they exploit signaling between healthy neurons and internalize portions of their contact sites. Dr. Dr. Varun Venkataramani of the Heidelberg Medical Faculty of Heidelberg University, and his research team, will investigate how glioblastoma cells benefit from this process and whether it may represent a novel therapeutic target.]]></description>
      <pubDate>Thu, 03 Sep 2026 11:57:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/article/press-release/erc-starting-grant-heidelberg-neurologist-and-neuroscientist-dr-dr-varun-venkataramani</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/article/press-release/erc-starting-grant-heidelberg-neurologist-and-neuroscientist-dr-dr-varun-venkataramani</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Early Detection of COPD: A Study in Freiburg Investigates a New Treatment</title>
      <description><![CDATA[Coughing, phlegm, and shortness of breath can be early signs of COPC. In COPD, the airways are permanently narrowed, making it harder to breathe. The most significant risk factor is long-term smoking. The CHRONOS study conducted by the Department of Pneumology at the Medical Center – University of Freiburg provides evidence that changes in the lungs can already be detected before a standard pulmonary function test confirms the airway narrowing.]]></description>
      <pubDate>Tue, 01 Sep 2026 14:57:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/article/press-release/early-detection-copd-study-freiburg-investigates-new-treatment</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/article/press-release/early-detection-copd-study-freiburg-investigates-new-treatment</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Health Innovation Nexus</title>
      <description><![CDATA[Kein Inhalt]]></description>
      <pubDate>Mon, 31 Aug 2026 10:10:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/event/health-innovation-nexus-en</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/event/health-innovation-nexus-en</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Outstanding success for Ulm’s quantum physics QuantERA funds four teams</title>
      <description><![CDATA[Research into quantum technology by four teams at Ulm University is being funded as part of the European QuantERA programme. This is more than at any other German university. The projects focus, for example, on more robust quantum computers and innovative medical diagnostic methods.]]></description>
      <pubDate>Fri, 28 Aug 2026 12:32:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/article/press-release/outstanding-success-ulms-quantum-physics-quantera-funds-four-teams</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/article/press-release/outstanding-success-ulms-quantum-physics-quantera-funds-four-teams</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Reaching the unreachable: new approaches to challenging drug targets</title>
      <description><![CDATA[Modern medicines act with remarkable precision. Antibodies, for example, recognise their molecular targets much like a key fits into its corresponding lock. However, certain targets like small molecules or carbohydrates remain difficult to target. The start-up Panosome aims to eliminate these blind spots with a novel immunotherapy platform that harnesses sophisticated masters of immune evasion: trypanosomes.]]></description>
      <pubDate>Wed, 26 Aug 2026 11:16:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/article/news/reaching-unreachable-new-approaches-challenging-drug-targets</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/article/news/reaching-unreachable-new-approaches-challenging-drug-targets</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Revier Therapeutics Launches with €6 Million Seed Financing to Pioneer Class IIa HDAC Inhibitors for Cardiometabolic Disease</title>
      <description><![CDATA[Revier Therapeutics, today announced the closing of a EUR 6 million seed financing and the launch of its operations. The Company has established the first therapeutic approach to selectively target class IIa histone deacetylases (HDACs) for the treatment of cardiometabolic diseases.]]></description>
      <pubDate>Tue, 25 Aug 2026 14:17:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/article/press-release/revier-therapeutics-launches-euro-6-million-seed-financing-pioneer-class-iia-hdac-inhibitors-cardiometabolic-disease</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/article/press-release/revier-therapeutics-launches-euro-6-million-seed-financing-pioneer-class-iia-hdac-inhibitors-cardiometabolic-disease</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Targeted Drug Delivery</title>
      <description><![CDATA[Kein Inhalt]]></description>
      <pubDate>Tue, 25 Aug 2026 07:45:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/event/targeted-drug-delivery-en</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/event/targeted-drug-delivery-en</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Swiss Nordic Bio 2026</title>
      <description><![CDATA[Kein Inhalt]]></description>
      <pubDate>Fri, 21 Aug 2026 13:30:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/event/swiss-nordic-bio-2026-en</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/event/swiss-nordic-bio-2026-en</guid>
      <slash:comments>0</slash:comments>
    </item>
  </channel>
</rss>
